Stocks · News reference
Guardian Pharmacy Service Raises FY2026 Sales Guidance from $1.400B-$1.420B to $1.430B-$1.450B vs $1.415B Est
Guardian Pharmacy Service (NYSE:GRDN) raises FY2026 sales outlook from $1.400 billion-$1.420 billion to $1.430 billion-$1.450 billion vs $1.415 billion estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 8:19 PM
- Checked
- Aug 6, 2026, 8:19 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $49
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $43 to $49.
Read original at benzingaGuardian Pharmacy Service Q2 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $351.768M Beat $340.045M Estimate
Guardian Pharmacy Service (NYSE:GRDN) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.27 by 7.41 percent. This is a 26.09 percent increase over earnings of $0.23 per share
Read original at benzinga